CD8A and cancer: IL-2/IL-2R signaling has contradictory immunomodulatory effects, since it not only facilitates proliferation of cytotoxic CD8 T cells that kill cancer cells, but also suppresses the immune response by promoting inhibitory CD4+ Treg cells [9–11].